Workflow
九典制药:实控人拟1000万元—2000万元增持公司股份
300705Hunan Jiudian Pharmaceutical (300705) 证券时报网·2025-01-17 09:54

Core Viewpoint - The company, Jiutian Pharmaceutical, announced that its controlling shareholder and chairman, Zhu Zhihong, plans to increase his stake in the company through the Shenzhen Stock Exchange within six months, with a total investment amount between 10 million and 20 million yuan [1] Group 1 - The controlling shareholder and actual controller of the company is Zhu Zhihong [1] - The planned share purchase will be conducted through centralized bidding on the Shenzhen Stock Exchange [1] - The total amount for the share buyback is set to be no less than 10 million yuan and no more than 20 million yuan [1]